Sativex® as Add-on therapy Vs. further optimized first-line...

  • Main
  • 2018 / 05
  • Sativex® as Add-on therapy Vs. further optimized first-line...

Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial

Markovà, Jolana, Essner, Ute, Akmaz, Bülent, Marinelli, Marcella, Trompke, Christiane, Lentschat, Arnd, Silván, Carlos Vila
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Neuroscience
DOI:
10.1080/00207454.2018.1481066
Date:
May, 2018
File:
PDF, 941 KB
english, 2018
Conversion to is in progress
Conversion to is failed